Delivery Order SPE2DB20D3103-SPE2DB24FP6B2

Award Date 7/19/24
Potential Completion Date 7/22/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,342.04 firm fixed-price delivery order is for the supply of 1,000 units of the medication Tamsulosin HCl 0.4 mg capsules. The contract has a period of performance through November 22, 2023 and was awarded on November 21, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,183.37 firm fixed-price delivery order is for the supply of Tamsulosin HCL 0.4 mg capsules, with a completion date of September 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,772.00 delivery order contract is for the supply of 4,565,675,754 units of the generic drug Tamsulosin HCL 0.4 mg capsules. The contract has a firm fixed price pricing type and an ultimate completion date of September 5, 2024. Amerisourcebergen holds a large $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,843.85 fixed-price contract is for the delivery of 1,000 units of the prescription medication Tamsulosin HCL 0.4 mg capsules, with a completion date of December 2, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,118.38, is for the supply of 1,000 units of Tamsulosin Hydrochloride 0.4 mg capsules. The contract has an ultimate completion date of January 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,561,823,091 units of Tamsulosin HCL 0.4 mg capsules. The contract has a firm fixed price of $5,949.44 and an ultimate completion date of August 16, 2023. The contract was awarded on August 15, 2023 and was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,326.16 firm-fixed-price delivery order is for the supply of 4,566,280,778 units of Tamsulosin HCL 0.4 mg capsules, with a completion date of October 31, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,481.86 firm fixed-price delivery order is for the supply of 1,000 units of the drug Tamsulosin HCL 0.4 mg capsules. The contract has a completion date of September 4, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,707,544 units of Tamsulosin HCL 0.4 mg capsules. The firm-fixed-price, $1,667.08 delivery order contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,463.04, is a Firm Fixed Price Delivery Order for the supply of Tamsulosin HCL 0.4 mg capsules. The contract has an ultimate completion date of January 30, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP6B2
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,118.77 firm fixed-price delivery order is for the supply of Tamsulosin HCL 0.4 mg capsules in 1,000-count units. The contract has a completion date of July 22, 2024 and was awarded on July 19, 2024.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is likely part of that larger IDC. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:29 AM